Consolidated balance sheet as at 31 December 2023
before profit appropriation
(in millions of euros) |
31 December 2023 |
31 December 2022* |
|
Assets |
|||
Property, plant and equipment |
3,317 |
3,442 |
|
Investment property |
122 |
119 |
|
Intangible assets |
203 |
319 |
|
Right-of-use assets |
268 |
446 |
|
Investments recognised using the equity method |
12 |
12 |
|
Other financial assets, including investments |
157 |
197 |
|
Deferred tax assets |
428 |
316 |
|
Total non-current assets |
4,507 |
4,851 |
|
Inventories |
177 |
220 |
|
Trade and other receivables |
516 |
676 |
|
Income tax receivable |
- |
- |
|
Other current financial assets, including investments |
715 |
745 |
|
Cash and cash equivalents |
460 |
396 |
|
Total current assets |
1,868 |
2,037 |
|
Assets held for sale |
- |
1,476 |
|
Total assets |
6,375 |
8,364 |
|
Equity and liabilities |
|||
Equity |
|||
Issued share capital |
1,012 |
1,012 |
|
Other reserves |
44 |
70 |
|
Retained earnings |
1,238 |
647 |
|
Unappropriated result |
-380 |
574 |
|
Capital and reserves due to shareholder |
1,914 |
2,303 |
|
Third-party minority interests |
- |
1 |
|
Equity |
1,914 |
2,304 |
|
Deferred income |
123 |
128 |
|
Loans and other financial liabilities, including derivatives |
1,672 |
1,505 |
|
Lease liabilities |
315 |
377 |
|
Employee benefits |
58 |
55 |
|
Provisions |
87 |
310 |
|
Accruals and deferred items |
8 |
9 |
|
Deferred tax liabilities |
- |
- |
|
Total non-current liabilities |
2,263 |
2,384 |
|
Loans and other financial liabilities, including derivatives |
387 |
296 |
|
Lease liabilities |
89 |
87 |
|
Income tax payable |
13 |
11 |
|
Trade and other liabilities |
1,004 |
1,306 |
|
Deferred income |
590 |
565 |
|
Provisions |
115 |
64 |
|
Total current liabilities |
2,198 |
2,329 |
|
Liabilities held for sale |
- |
1,347 |
|
Total liabilities |
4,461 |
6,060 |
|
Total equity and liabilities |
6,375 |
8,364 |
- *Due to adjustment of the value of negative goodwill within one year of acquisition, financial income was retrospectively adjusted by €5 million negative. The comparative figures for 2022 have been adjusted for this. See note 32.